Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klintmalm, G. B.
Right arrow Articles by Starzl, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klintmalm, G. B.
Right arrow Articles by Starzl, T. E.

Radiology, Vol 142, 199-202, Copyright © 1982 by Radiological Society of North America

ARTICLES

99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A

GB Klintmalm, WC Klingensmith 3d, S Iwatsuki, GP Schroter and TE Starzl

The effects of cyclosporin A (CyA), an immunosuppressive agent that is potentially nephrotoxic, on the kidneys of 9 liver transplant recipients were studied with serial 99mTc-DTPA and 131I-hippuran scans. In addition, renal function was determined by measuring serum creatinine levels during the second postoperative week in the 9 unselected CyA-treated patients and, retrospectively, in a control group of 29 liver transplant recipients who had not been treated with CyA and who were selected because they had survived for at least 3 months postoperatively. The early postoperative creatinine level was significantly greater in the CyA group. Eight of the 9 CyA patients showed imaging abnormalities in all preoperative and postoperative studies. Five of the 8 patients showed a pattern similar to that of acute tubular necrosis (relatively preserved perfusion) in at least one study. Lowering the dosage of CyA permitted the continuation of therapy, and all 9 patients are alive after 8 to 14 months.


This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
A Owunwanne, A Shihab-Eldeen, T Yacoub, and G Ziada
The use of radiopharmaceuticals as an effective toxicologic technique for studying nephrotoxicity of drugs: cyclosporine-A
Human and Experimental Toxicology, November 1, 1998; 17(11): 613 - 619.
[Abstract] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
R. J. Kowalsky and J. A. Ponto
A Basic Overview of Radiopharmaceuticals and Their Relationship to Nuclear Pharmacy Practice
Journal of Pharmacy Practice, January 1, 1989; 2(3): 139 - 147.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1982 by the Radiological Society of North America.